Pasithea Therapeutics Corp. The company is headquartered in Miami Beach, Florida.
| Revenue (TTM) | 486,560 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-16.03M |
| Operating Margin | 0.00% |
| Return on Equity | -58.40% |
| Return on Assets | -27.40% |
| Revenue/Share (TTM) | $0.37 |
| Book Value | $2.39 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $10.20M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |